Trials / Recruiting
RecruitingNCT05217407
Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
A Prospective Clinical Registry Study of Genetic Profiling and Targeted Therapies in Patients With Rare Cancers in ASIA
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- National Cancer Center, Japan · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a registry study that aims to collect patients' data with advanced-stage rare cancer in Asia-Pacific region. Data includes clinical information, details of treatment, prognosis, pathological diagnosis and genetic biomarkers by next-generation sequencing. The relationship between cancer types and prognosis, the effect of treatments, and the cancer type-specific incidence of genomic alterations will be investigated to discover more specific and effective treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Genomic sequence | Genomic sequence |
Timeline
- Start date
- 2021-11-30
- Primary completion
- 2027-03-31
- Completion
- 2030-03-31
- First posted
- 2022-02-01
- Last updated
- 2024-03-22
Locations
18 sites across 7 countries: Japan, Malaysia, Philippines, South Korea, Taiwan, Thailand, Vietnam
Source: ClinicalTrials.gov record NCT05217407. Inclusion in this directory is not an endorsement.